`Date Filed: Oct. 12, 2016
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`JANSSEN ONCOLOGY, INC.,
`Patent Owner.
`
`________________
`
`Case IPR2016-01332
`Patent 8,822,438
`
`________________
`
`JANSSEN ONCOLOGY, INC.’S UPDATED EXHIBIT LIST
`
`
`
`IPR2016-01332
`Patent No. 8,822,438
`
`Pursuant to 37 C.F.R. § 42.63(e), Petitioner, Janssen Oncology, Inc. hereby
`
`submits a current list of its exhibits.
`
`Exhibit
`
`JSN 2001
`
`Description
`
`Notice of Termination of Preprocessing of Ex Parte Reexamination
`
`Request
`
`JSN 2002
`
`Declaration of David T. Pritikin in Support of Motion to Appear
`
`Pro Hac Vice
`
`JSN 2003
`
`Declaration of Bindu Donovan in Support of Motion to Appear
`
`Pro Hac Vice
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`/Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`
`
`
`
`1
`
`Date: Oct 12, 2016
`
`
`
`
`
`
`
`IPR2016-01332
`Patent No. 8,822,438
`
`CERTIFICATE OF SERVICE
`
`
`
`The undersigned hereby certifies that a copy of the foregoing Janssen
`
`Oncology, Inc.’s Updated Exhibit List was served on counsel of record on October
`
`12, 2016 by filing this document through the End-to-End System, as well as
`
`delivering a copy via electronic mail to counsel of record for the Petitioner at the
`
`following addresses:
`
`Brandon M. White – bmwhite@perkinscoie.com
`Bryan D. Beel – bbeel@perkinscoie.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`By: /Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`
`2
`
`
`
`Date: Oct. 12, 2016